198 related articles for article (PubMed ID: 15614152)
1. Comparison between C0 and C2 monitoring in de novo renal transplant recipients: retrospective analysis of a single-center experience.
Bîrsan T; Loinig C; Bodingbauer M; Wekerle T; Rockenschaub S; Berlakovich G; Soliman T; Mühlbacher F; Steininger R
Transplantation; 2004 Dec; 78(12):1787-91. PubMed ID: 15614152
[TBL] [Abstract][Full Text] [Related]
2. Early cyclosporine C0 and C2 monitoring in de novo kidney transplant patients: a prospective randomized single-center pilot study.
Kyllönen LE; Salmela KT
Transplantation; 2006 Apr; 81(7):1010-5. PubMed ID: 16612277
[TBL] [Abstract][Full Text] [Related]
3. Absorption profiling of cyclosporine microemulsion (neoral) during the first 2 weeks after renal transplantation.
Canadian Neoral Renal Transplantation Study Group
Transplantation; 2001 Sep; 72(6):1024-32. PubMed ID: 11579295
[TBL] [Abstract][Full Text] [Related]
4. Clinical outcomes during the first three months posttransplant in renal allograft recipients managed by C2 monitoring of cyclosporine microemulsion.
Thervet E; Pfeffer P; Scolari MP; Toselli L; Pallardó LM; Chadban S; Pilmore H; Connolly J; Buchler M; Schena FP; Carreño CA; Dandavino R; Cole E
Transplantation; 2003 Sep; 76(6):903-8. PubMed ID: 14508352
[TBL] [Abstract][Full Text] [Related]
5. Cyclosporine minimization and cost reduction in renal transplant recipients receiving a C2-monitored, cyclosporine-based quadruple immunosuppressive regimen.
Hardinger KL; Schnitzler MA; Koch MJ; Enkvetchakul D; Desai N; Jendrisak M; Lowell JA; Miller B; Shenoy S; Brennan DC
Transplantation; 2004 Oct; 78(8):1198-203. PubMed ID: 15502720
[TBL] [Abstract][Full Text] [Related]
6. Cyclosporine monitoring with 2-hour postdose levels in heart transplant recipients.
Solari SG; Goldberg LR; DeNofrio D; Shaw LM
Ther Drug Monit; 2005 Aug; 27(4):417-21. PubMed ID: 16044096
[TBL] [Abstract][Full Text] [Related]
7. Comparison of cyclosporine concentrations 2 hours post-dose determined using 3 different methods and trough level in pediatric renal transplantation.
Rodríguez E; Delucchi MA; Cano F; Valdebenito S; Castillo MC; Villegas R
Transplant Proc; 2005 Oct; 37(8):3354-7. PubMed ID: 16298594
[TBL] [Abstract][Full Text] [Related]
8. Two-hour post-dose cyclosporine levels in renal transplantation in Argentina: a cost-effective strategy for reducing acute rejection.
Balshaw R; Machnicki G; Carreño CA; Toselli L; Otero A; Keown PA
Transplant Proc; 2005 Mar; 37(2):871-4. PubMed ID: 15848560
[TBL] [Abstract][Full Text] [Related]
9. Improved clinical outcomes for liver transplant recipients using cyclosporine monitoring based on 2-hr post-dose levels (C2).
Levy G; Burra P; Cavallari A; Duvoux C; Lake J; Mayer AD; Mies S; Pollard SG; Varo E; Villamil F; Johnston A
Transplantation; 2002 Mar; 73(6):953-9. PubMed ID: 11923699
[TBL] [Abstract][Full Text] [Related]
10. Comparison of C0 and C2 cyclosporine monitoring in long-term renal transplant recipients.
Marcén R; Pascual J; Tato A; Villafruela JJ; Teruel JL; Rivera ME; Tenorio M; Fernández M; Burgos FJ; Ortuño J
Transplant Proc; 2003 Aug; 35(5):1780-2. PubMed ID: 12962793
[TBL] [Abstract][Full Text] [Related]
11. Comparison of trough, 2-hour, and limited AUC blood sampling for monitoring cyclosporin (Neoral) at day 7 post-renal transplantation and incidence of rejection in the first month.
Morris RG; Russ GR; Cervelli MJ; Juneja R; McDonald SP; Mathew TH
Ther Drug Monit; 2002 Aug; 24(4):479-86. PubMed ID: 12142630
[TBL] [Abstract][Full Text] [Related]
12. Cyclosporine profiling with C2 and C0 monitoring improves outcomes after heart transplantation.
Barnard JB; Thekkudan J; Richardson S; Bittar MN; Martyszczuck R; Hasan J; Khasati N; Keevil B; Yonan N
J Heart Lung Transplant; 2006 May; 25(5):564-8. PubMed ID: 16678036
[TBL] [Abstract][Full Text] [Related]
13. Evolution of the absorption profile of cyclosporine A in renal transplant recipients: a longitudinal study of the de novo and maintenance phases.
Büchler M; Chadban S; Cole E; Midtvedt K; Thervet E; Prestele H; Keown P
Nephrol Dial Transplant; 2006 Jan; 21(1):197-202. PubMed ID: 16204301
[TBL] [Abstract][Full Text] [Related]
14. Results of lis2t, a multicenter, randomized study comparing cyclosporine microemulsion with C2 monitoring and tacrolimus with C0 monitoring in de novo liver transplantation.
Levy G; Villamil F; Samuel D; Sanjuan F; Grazi GL; Wu Y; Marotta P; Boillot O; Muehlbacher F; Klintmalm G;
Transplantation; 2004 Jun; 77(11):1632-8. PubMed ID: 15201658
[TBL] [Abstract][Full Text] [Related]
15. Impact of cyclosporine 2-h level and mycophenolate mofetil dose on clinical outcomes in de novo heart transplant patients receiving anti-thymocyte globulin induction.
Cantarovich M; Giannetti N; Cecere R
Clin Transplant; 2003 Apr; 17(2):144-50. PubMed ID: 12709082
[TBL] [Abstract][Full Text] [Related]
16. C2 monitoring in maintenance renal transplant recipients: is it worthwhile?
Midtvedt K; Fauchald P; Bergan S; Høieggen A; Hallan S; Svarstad E; Bergrem H; Eriksen BO; Pfeffer PF; Dalen I; Leivestad T
Transplantation; 2003 Oct; 76(8):1236-8. PubMed ID: 14578761
[TBL] [Abstract][Full Text] [Related]
17. Cyclosporine C2 levels have impact on incidence of rejection in de novo lung but not heart transplant recipients: the NOCTURNE study.
Iversen M; Nilsson F; Sipponen J; Eiskjaer H; Mared L; Bergan S; Nyström U; Fagertun HE; Solbu D; Simonsen S
J Heart Lung Transplant; 2009 Sep; 28(9):919-26. PubMed ID: 19716045
[TBL] [Abstract][Full Text] [Related]
18. 12-month follow-up analysis of a multicenter, randomized, prospective trial in de novo liver transplant recipients (LIS2T) comparing cyclosporine microemulsion (C2 monitoring) and tacrolimus.
Levy G; Grazi GL; Sanjuan F; Wu Y; Mühlbacher F; Samuel D; Friman S; Jones R; Cantisani G; Villamil F; Cillo U; Clavien PA; Klintmalm G; Otto G; Pollard S; McCormick PA
Liver Transpl; 2006 Oct; 12(10):1464-72. PubMed ID: 17004259
[TBL] [Abstract][Full Text] [Related]
19. Analysis of liver function in renal transplant recipients undergoing C2-monitoring for cyclosporine.
Hecking M; Kainz A; Schillinger M; Posch C; Birsan T; Rasoul-Rockenschaub S; Böhmig GA; Schmaldienst S; Watschinger B; Hörl WH; Mühlbacher F; Säemann MD
Transpl Int; 2008 Mar; 21(3):223-33. PubMed ID: 17903183
[TBL] [Abstract][Full Text] [Related]
20. C2 is superior to C0 as predictor of renal toxicity and rejection risk profile in stable heart transplant recipients.
Caforio AL; Tona F; Piaserico S; Gambino A; Feltrin G; Fortina AB; Angelini A; Alaibac M; Bontorin M; Calzolari D; Peserico A; Thiene G; Iliceto S; Gerosa G
Transpl Int; 2005 Jan; 18(1):116-24. PubMed ID: 15612993
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
